225 related articles for article (PubMed ID: 19408055)
21. [Dermatomyositis associated with hepatosplenic gamma delta T-cell lymphoma].
Chandesris MO; Crétel-Durand E; Jean R; Rey J; Figarella-Branger D; Sainty D; Durand JM
Rev Med Interne; 2007 Aug; 28(8):552-5. PubMed ID: 17559983
[TBL] [Abstract][Full Text] [Related]
22. Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma.
O'Connor OA; Hamlin PA; Portlock C; Moskowitz CH; Noy A; Straus DJ; Macgregor-Cortelli B; Neylon E; Sarasohn D; Dumetrescu O; Mould DR; Fleischer M; Zelenetz AD; Sirotnak F; Horwitz S
Br J Haematol; 2007 Nov; 139(3):425-8. PubMed ID: 17910632
[TBL] [Abstract][Full Text] [Related]
23. Hepatosplenic T-cell lymphoma is a distinct rare entity: diagnosis by fine-needle aspiration cytology.
Kumar R; Dey P; Das A; Sachdeva MS; Varma S
Diagn Cytopathol; 2011 Sep; 39(9):677-80. PubMed ID: 21837655
[TBL] [Abstract][Full Text] [Related]
24. Retinal hemorrhages as a presenting sign in an adolescent patient with hepatosplenic gamma-delta T-cell lymphoma.
Edwards J; Simmons E; Cordero S; Lieuw K; Roberts S
Pediatr Blood Cancer; 2010 Jul; 55(1):190-2. PubMed ID: 20486185
[TBL] [Abstract][Full Text] [Related]
25. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation.
Gassas A; Kirby M; Weitzman S; Ngan B; Abla O; Doyle JJ
Am J Hematol; 2004 Feb; 75(2):113-4. PubMed ID: 14755380
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma.
Rashidi A; Cashen AF
Blood Cancer J; 2015 Jun; 5(6):e318. PubMed ID: 26047388
[No Abstract] [Full Text] [Related]
27. [Hemophacocytic syndrome as early sign for hepatosplenic T-cell lymphoma in a patient with chronic lymphocytic leukaemia].
Picque M; Khoury E; Lenoble M; Chait Y
Ann Biol Clin (Paris); 2014; 72(2):241-4. PubMed ID: 24736146
[TBL] [Abstract][Full Text] [Related]
28. A rare case of hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8.
Jain H; Shetty D; Jain H; Sengar M; Khattry N; Subramanian PG
Cancer Genet; 2018 Dec; 228-229():17-20. PubMed ID: 30553467
[TBL] [Abstract][Full Text] [Related]
29. Pralatrexate, a dihydrofolate reductase inhibitor for the potential treatment of several malignancies.
Molina JR
IDrugs; 2008 Jul; 11(7):508-21. PubMed ID: 18600598
[TBL] [Abstract][Full Text] [Related]
30. Fulminant liver failure induced by hepatosplenic alphabeta T-cell lymphoma.
Petersen-Benz C; Hoffmann N; Beckurts T; Goeser T; Steffen HM; Dries V
Z Gastroenterol; 2003 Nov; 41(11):1083-6. PubMed ID: 14648377
[TBL] [Abstract][Full Text] [Related]
31. Gastroenterology: Hepatosplenic T cell lymphoma associated with schistosomiasis.
Azevedo P; Pedrosa MS; Resende V
J Gastroenterol Hepatol; 2015 Sep; 30(9):1333. PubMed ID: 26211690
[No Abstract] [Full Text] [Related]
32. Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?
Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J
Intern Med J; 2014 Mar; 44(3):287-90. PubMed ID: 24621284
[TBL] [Abstract][Full Text] [Related]
33. Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma.
Shimanovsky A; Dasanu CA
Expert Opin Pharmacother; 2013 Mar; 14(4):515-23. PubMed ID: 23409799
[TBL] [Abstract][Full Text] [Related]
34. Pralatrexate (Folotyn).
Abramovits W; Oquendo M; Granowski P; Gupta A; Cather J
Skinmed; 2012; 10(4):244-6. PubMed ID: 23008944
[TBL] [Abstract][Full Text] [Related]
35. Case report: a common presentation of a rare disease-hepatosplenic T-cell lymphoma.
Munir J; Preston G; Polish R
Hawaii Med J; 2004 Nov; 63(11):341-3. PubMed ID: 15633661
[TBL] [Abstract][Full Text] [Related]
36. Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature.
Roelandt PR; Maertens J; Vandenberghe P; Verslype C; Roskams T; Aerts R; Nevens F; Dierickx D
Liver Transpl; 2009 Jul; 15(7):686-92. PubMed ID: 19562701
[TBL] [Abstract][Full Text] [Related]
37. Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy.
Bennett M; Matutes E; Gaulard P
Am J Hematol; 2010 Sep; 85(9):727-9. PubMed ID: 20652973
[TBL] [Abstract][Full Text] [Related]
38. A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.
Albayrak M; Balcik OS; Alan S; Dıncer SL; Yüksel MK; Albayrak A
Pathol Oncol Res; 2011 Jun; 17(2):421-3. PubMed ID: 21197592
[No Abstract] [Full Text] [Related]
39. Gamma-delta t-cell lymphomas.
Foppoli M; Ferreri AJ
Eur J Haematol; 2015 Mar; 94(3):206-18. PubMed ID: 25154298
[TBL] [Abstract][Full Text] [Related]
40. Minimally invasive surgery for splenic malignancies.
Telem D; Chin EH; Colon M; Nguyen SQ; Weber K; Divino CM
Minerva Chir; 2008 Dec; 63(6):529-40. PubMed ID: 19078885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
